Eurospital manufactures and commercializes pharmaceutical products, medical-surgical and in vitro diagnostic devices.
Eurospital aims at being No. 1 in the specific markets where it operates in order to give its customers with the highest quality systems and services. To succeed Eurospital has to be able to renew itself and progress continuously in time and to set for itself increasingly ambitious goals. At Medica 2016, Eurospital will launch Calprest NG the New Generation reference system for the detection of Calprotectin. Its widest detection range (0 - 3000 mg/kg) makes Calprest NG the new reference test for Inflammatory Bowel Diseases.
Eurospital: innovative, state-of-the-art and complete panel of systems, customized customer support for long-term lasting partnership.